Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, Alix, Polydoro, Manuela, Suárez-Calvet, Marc, William, Christopher, Adamowicz, David H., Kopeikina, Kathy J., Pitstick, Rose, Sahara, Naruhiko +4 more·2012·Neuron
DOI 10.1016/j.neuron.2011.11.033

Cited by (1,003)

Items 601–700 of 1,003

  1. PAC1 receptor–mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain
    Ari W. Schaler, Avery M. Runyan, Catherine L. Taylor Clelland, Eric J. Sydney, Stephanie L. Fowler, Helen Y. Figueroa, Seiji Shioda, Ismael Santa‐María, Karen Duff, Natura Myeku · 2021 · Science Translational Medicine
  2. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer’s disease – Evidence from an MRI-based meta-analysis
    Marthe Mieling, Hannah Meier, Nico Bunzeck · 2023 · Neuroscience & Biobehavioral Reviews
  3. Imaging markers of structural and functional brain changes that precede cognitive symptoms in risk for Alzheimer’s disease
    Alison C. Burggren, Jesse A. Brown · 2013 · Brain Imaging and Behavior
  4. Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
    Astrid Sydow, Katja Hochgräfe, Stefanie Könen, Daniela Cadinu, Dorthe Matenia, Olga M. Petrova, Maria Joseph, Frank J.A. Dennissen, Eva‐Maria Mandelkow · 2016 · Acta Neuropathologica Communications
  5. Differences in Aβ brain networks in Alzheimer's disease and healthy controls
    Huoqiang Duan, Jiehui Jiang, Jun Liang Xu, Hucheng Zhou, Zhemin Huang, Zhihua Yu, Zhuangzhi Yan · 2016 · Brain Research
  6. Peripheral inflammation promotes brain tau transmission via disrupting blood–brain barrier
    Yanchao Liu, Shujuan Zhang, Xiaoguang Li, Enjie Liu, Xin Wang, Qiuzhi Zhou, Jinwang Ye, Jian‐Zhi Wang · 2020 · Bioscience Reports
  7. Stress and the Etiopathogenesis of Alzheimer’s Disease and Depression
    Ioannis Sotiropoulos, Joana Margarida Silva, Patrícia Gomes, Nuno Sousa, Osborne F. X. Almeida · 2019 · Advances in experimental medicine and biology
  8. Neuronal Oscillations on Evolving Networks: Dynamics, Damage, Degradation, Decline, Dementia, and Death
    Alain Goriely, Ellen Kuhl A, Christian Bick · 2020 · Physical Review Letters
  9. An update on the association between traumatic brain injury and Alzheimer’s disease: Focus on Tau pathology and synaptic dysfunction
    Liangping Li, Jiawen Liang, Hongjun Fu · 2020 · Neuroscience & Biobehavioral Reviews
  10. Exosomal and vesicle‐free tau seeds—propagation and convergence in endolysosomal permeabilization
    Juan Carlos Polanco, Jürgen Götz · 2021 · FEBS Journal
  11. The Prion-Like Behavior of Assembled Tau in Transgenic Mice
    Florence Clavaguera, Markus Tolnay, Michel Goedert · 2016 · Cold Spring Harbor Perspectives in Medicine
  12. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice
    Mark K. Schultz, Renee C. Gentzel, Marija Usenovic, Cheryl A. Gretzula, C. Ware, Sophie Parmentier‐Batteur, Joel B. Schachter, Hatim A. Zariwala · 2018 · Neurobiology of Disease
  13. The Pathophysiology of Tau and Stress Granules in Disease
    Anna Lourdes Cruz, Mamta Verma, Benjamin L. Wolozin · 2019 · Advances in experimental medicine and biology
  14. Network Diffusion Modeling Explains Longitudinal Tau PET Data
    Amelie Schäfer, Elizabeth C. Mormino, Ellen Kuhl A · 2020 · Frontiers in Neuroscience
  15. Cerebrospinal Fluid Levels of a 20–22 kDa NH2 Fragment of Human Tau Provide a Novel Neuronal Injury Biomarker in Alzheimer's Disease and Other Dementias
    Giuseppina Amadoro, Veronica Corsetti, Giulia Maria Sancesario, Adele Lubrano, Gaia Melchiorri, Sergio Bernardini, Pietro Calissano, Giuseppe Sancesario · 2014 · Journal of Alzheimer s Disease
  16. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy
    Tara L. Spires‐Jones, Taylor Friedman, Rose Pitstick, Manuela Polydoro, Allyson D. Roe, George A. Carlson, Bradley T. Hyman · 2014 · Neuroscience Letters
  17. Anti-Tau Antibodies Based Electrochemical Sensor for Detection of Tau Protein Biomarkers
    Nicholas Carlin, Sanela Martić · 2018 · Journal of The Electrochemical Society
  18. Alzheimer’s Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging
    Kaitlin E. Cassady, Jenna N. Adams, Xi Chen, Anne Maaß, Theresa M. Harrison, Susan M. Landau, Suzanne L. Baker, William J. Jagust · 2021 · Cerebral Cortex
  19. Chronic Effects of Mild Neurotrauma: Putting the Cart Before the Horse?
    Castellani, Rudy J., Perry, George, Iverson, Grant L. · 2015 · Journal of Neuropathology & Experimental Neurology
  20. Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis
    Selenica, Maj-Linda B, Davtyan, Hayk, Housley, Steven B, Blair, Laura J, Gillies, Anne, Nordhues, Bryce A, Zhang, Bo, Liu, Joseph, Gestwicki, Jason E, Lee, Daniel C et al. · 2014 · Journal of Neuroinflammation
  21. Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly
    Erin E. Congdon, Yixiang Jiang, Einar M. Sigurdsson · 2021 · Seminars in Cell and Developmental Biology
  22. Type-I Interferons in Alzheimer's Disease and Other Tauopathies
    Sophie Sanford, William A. McEwan · 2022 · Frontiers in Cellular Neuroscience
  23. Causal links among amyloid, tau, and neurodegeneration
    Murat Bilgel, Dean Foster Wong, Abhay Moghekar, Luigi Ferrucci, Susan M. Resnick, the Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Communications
  24. Tau as the Converging Protein between Chronic Stress and Alzheimer's Disease Synaptic Pathology
    Ioannis Sotiropoulos, Nuno Sousa · 2015 · Neurodegenerative Diseases
  25. Reversible Cation-Selective Attachment and Self-Assembly of Human Tau on Supported Brain Lipid Membranes
    Stefania Anna Mari, Susanne Wegmann, Katharina Tepper, Bradley T. Hyman, Eva‐Maria Mandelkow, Eckhard Mandelkow�, Daniel J. Müller · 2018 · Nano Letters
  26. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies
    Salvatore Spina, Jesse A. Brown, Jersey Deng, Raquel C. Gardner, Alissa L. Nana, Ji-Hye L Hwang, Stephanie E. Gaus, Eric Jinsheng Huang, Joel H. Kramer, Howie J. Rosen et al. · 2019 · Brain
  27. Synthesis and biological evaluation of 3–(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer’s disease agents
    Yuheng Hu, Jie Wu Yang, Yun Liang Zhang, Kechun Liu, Teng Liu, Jie Sun, Xiaojing Wang · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
  28. Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.
    Alyenbaawi, Hadeel, Kanyo, Richard, Locskai, Laszlo F, Kamali-Jamil, Razieh, DuVal, Michèle G, Bai, Qing, Wille, Holger, Burton, Edward A, Allison, W Ted · 2021 · eLife
  29. Functional network segregation is associated with attenuated tau spreading in Alzheimer's disease
    Steward, Anna, Biel, Davina, Brendel, Matthias, Dewenter, Anna, Roemer, Sebastian, Rubinski, Anna, Luan, Ying, Dichgans, Martin, Ewers, Michael, Franzmeier, Nicolai et al. · 2023 · Alzheimer's & Dementia
  30. All the Tau We Cannot See
    Hyman, Bradley · 2023 · Annual Review of Medicine
  31. Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
    Meyer, Virginia, Dinkel, Paul D., Luo, Yin, Yu, Xiang, Wei, Guanghong, Zheng, Jie, Eaton, Gareth R., Ma, Buyong, Nussinov, Ruth, Eaton, Sandra S. et al. · 2014 · Angewandte Chemie International Edition
  32. The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in in Vitro Systems and Their Therapeutic Implications
    Maria Masnata, Francesca Cicchetti · 2017 · Frontiers in Neuroscience
  33. Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo
    Marc Vandermeeren, Marianne Borgers, Kristof Van Kolen, Clara Theunis, Bruno Vasconcelos, Astrid Bottelbergs, Cindy Wintmolders, Guy Daneels, Roland Willems, Koen Dockx et al. · 2018 · Journal of Alzheimer s Disease
  34. Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain
    Detrez, Jan R., Maurin, Hervé, Van Kolen, Kristof, Willems, Roland, Colombelli, Julien, Lechat, Benoit, Roucourt, Bart, Van Leuven, Fred, Baatout, Sarah, Larsen, Peter et al. · 2019 · Neurobiology of Disease
  35. Photo-oxygenation inhibits tau amyloid formation
    Takanobu Suzuki, Yukiko Hori, Taka Sawazaki, Yusuke Shimizu, Yu Nemoto, Atsuhiko Taniguchi, Shuta Ozawa, Youhei Sohma, Motomu Kanai, Taisuke Tomita · 2019 · Chemical Communications
  36. Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
    Samantha De La‐Rocque, Edoardo Moretto, Ioana Butnaru, Giampietro Schiavo · 2020 · Journal of Neurochemistry
  37. Critical Molecular and Cellular Contributors to Tau Pathology
    Liqing Song, Evan A. Wells, Anne Skaja Robinson · 2021 · Biomedicines
  38. Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer’s Disease Patients
    Udo Rüb, Katharina Stratmann, Helmut Heinsen, Domenico Del Turco, Estifanos Ghebremedhin, Kay Seidel, Wilfred F.A. den Dunnen, Horst‐Werner Korf · 2015 · Journal of Alzheimer s Disease
  39. MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research
    Eduardo Rigon Zimmer, Maxime J. Parent, A. Claudio Cuello, Serge G. Gauthier, Pedro Rosa‐Neto · 2014 · Trends in Neurosciences
  40. Targeting Axonal Protein Synthesis in Neuroregeneration and Degeneration
    Jimena Baleriola, Ulrich Hengst · 2014 · Neurotherapeutics
  41. Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging
    Masafumi Shimojo, Makoto Higuchi, Tetsuya Suhara, Naruhiko Sahara · 2015 · Frontiers in Neuroscience
  42. Inflammation as a Possible Link Between Dyslipidemia and Alzheimer’s Disease
    Bruno Cabral de Lima Oliveira, Paula Maria Quaglio Bellozi, Helton José Reis, Antônio Carlos Pinheiro de Oliveira · 2018 · Neuroscience
  43. Bayesian Physics-Based Modeling of Tau Propagation in Alzheimer's Disease
    Amelie Schäfer, Mathias Peirlinck, Kevin Linka, Ellen Kuhl A, The Alzheimer's Disease Neuroimaging Initiative (ADNI) · 2021 · Frontiers in Physiology
  44. Wolframin is a novel regulator of tau pathology and neurodegeneration
    Shuo Chen, Diana M. Acosta, Liangping Li, Jiawen Liang, Yuzhou Chang, Cankun Wang, Julie Fitzgerald, Cody T. Morrison, Chris N. Goulbourne, Yoshi Nakano et al. · 2022 · Acta Neuropathologica
  45. Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution
    Cristina Vergara, Lara Ordóñez‐Gutiérrez, Francisco G. Wandosell, Isidró Ferrer, José Antonio del Rı́o, Rosalina Gavı́n · 2014 · Molecular Neurobiology
  46. Sevoflurane anaesthesia induces cognitive impairment in young mice through sequential tau phosphorylation
    Feng Liang, Mengzhu Li, Miao Xu, Yiying Zhang, Yuanlin Dong, Sulpicio G. Soriano, Mary Ellen McCann, Guang Yang, Zhongcong Xie · 2023 · British Journal of Anaesthesia
  47. Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Sarah K. Kaufman, Marc I. Diamond · 2013 · Neurotherapeutics
  48. Genetic underpinnings in Alzheimer’s disease – a review
    Ahmed A. Moustafa, Mubashir Hassan, Doaa H. Hewedi, Iman H. Hewedi, Julia K. Garami, Hany Alashwal, Nazar Zaki, Sung‐Yum Seo, Vassilis Cutsuridis A, Sergio L. Angulo et al. · 2017 · Reviews in the Neurosciences
  49. Evidence of corticofugal tau spreading in patients with frontotemporal dementia
    Eun‐Joo Kim, Jihye Hwang, Stephanie E. Gaus, Alissa L. Nana, Jersey Deng, Jesse A. Brown, Salvatore Spina, Myung Jun Lee, Eliana Marisa Ramos, Lea T. Grinberg et al. · 2019 · Acta Neuropathologica
  50. The molecular processes underpinning prion-like spreading and seed amplification in protein aggregation
    Georg Meisl, Tuomas P. J. Knowles, David Klenerman · 2020 · Current Opinion in Neurobiology
  51. Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro
    Soo Jung Shin, Yong Ho Park, Seong Gak Jeon, Sujin Kim, Yunkwon Nam, Sang‐Muk Oh, Yong Yook Lee, Minho Moon · 2020 · Oxidative Medicine and Cellular Longevity
  52. The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies
    Zein Amro, Andrea J. Yool, Lyndsey E. Collins‐Praino · 2021 · Brain Behavior & Immunity - Health
  53. Activation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer’s Disease
    Francisca Villavicencio-Tejo, Margrethe A. Olesen, Alejandra Aránguiz, Rodrigo A. Quintanilla · 2022 · Antioxidants
  54. Assessing mild cognitive impairment using object‐location memory in immersive virtual environments
    Andrea Castegnaro, David Howett, Adrienne Li, Elizabeth Harding, Dennis Chan, Neil Burgess, John A. King · 2022 · Hippocampus
  55. Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
    Kristen Marciniuk, Ryan Taschuk, Scott Napper · 2013 · Clinical and Developmental Immunology
  56. Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer’s disease synapse model
    Tetsuya Hori, Kohgaku Eguchi, Han-Ying Wang, Tomohiro Miyasaka, Laurent Guillaud, Zacharie Taoufiq, Satyajit Mahapatra, Hiroshi Yamada, Kohji Takei, Tomoyuki Takahashi · 2022 · eLife
  57. Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome-mediated proteolysis and attenuates tauopathy and cognitive decline
    Ari W. Schaler, Natura Myeku · 2017 · Translational research
  58. Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
    Hasan A. M. M. Almansoub, Hui Ru Tang, Ying Wu, Ding‐Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He, Dan Liu · 2018 · Journal of Alzheimer s Disease
  59. Relevance of host tau in tau seeding and spreading in tauopathies
    Isidró Ferrer, María Victoria Zelaya, Meritxell Aguiló, Margarita Carmona, Irene López‐González, Pol Andrés‐Benito, Laia Lidón, Rosalina Gavı́n, Paula Garcia‐Esparcia, José Antonio del Rı́o · 2019 · Brain Pathology
  60. Tract-defined regional white matter hyperintensities and memory
    Batool M. Rizvi, Patrick J. Lao, Juliet M. Colón, Christiane Hale, Kay Chioma Igwe, Atul Narkhede, Mariana Budge, Jennifer Jaie Manly, Nicole Schupf, Adam M. Brickman · 2019 · NeuroImage Clinical
  61. A probabilistic atlas of locus coeruleus pathways to transentorhinal cortex for connectome imaging in Alzheimer's disease
    Wei Sun, Yuchun Tang, Yuchuan Qiao, Xinting Ge, Mara Mather, John Matthew Ringman, Yonggang Shi · 2020 · NeuroImage
  62. Electroacupuncture Protects Cognition by Regulating Tau Phosphorylation and Glucose Metabolism via the AKT/GSK3β Signaling Pathway in Alzheimer’s Disease Model Mice
    Anping Xu, Qingtao Zeng, Yinshan Tang, Xin Wang, Xiaochen Yuan, You Zhou, Zhigang Li · 2020 · Frontiers in Neuroscience
  63. Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta
    Vasil Kecheliev, Leo Boss, Upasana Maheshwari, Uwe Konietzko, Annika Keller, Daniel Razansky, Roger M. Nitsch, Jan Klohs, Ruiqing Ni · 2023 · Life Sciences
  64. Schisantherin B ameliorates Aβ 1–42 -induced cognitive decline via restoration of GLT-1 in a mouse model of Alzheimer's disease
    Mengjie Xu, Yan Dong, Shutong Wan, Tingxu Yan, Jingdi Cao, Lidan Wu, Kaishun Bi, Ying Jia · 2016 · Physiology & Behavior
  65. Sources of Extracellular Tau and its Signaling
    Jesús Ávila, Diana Simón, Miguel Dı́az-Hernández, Jesús J. Pintor, Félix Hernández · 2014 · Journal of Alzheimer s Disease
  66. ER stress signaling and neurodegeneration: At the intersection between Alzheimer's disease and Prion-related disorders
    Mauricio Torres, José Manuel Matamala, Claudia A. Duran-Aniotz, Víctor Hugo Cornejo, Andrew Foley, Claudio A. Hetz · 2014 · Virus Research
  67. Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex
    Michael J. Yetman, Sveinung Lillehaug, Jan Gunnar Bjaalie, Trygve Brauns Leergaard, Joanna L. Jankowsky · 2015 · Brain Structure and Function
  68. Localizing Sources of Brain Disease Progression with Network Diffusion Model
    Chenhui Hu, Xue Hua, Jun Ying, Paul M. Thompson, Georges El Fakhri, Quanzheng Li · 2016 · IEEE Journal of Selected Topics in Signal Processing
  69. Cerebral vascular amyloid seeds drive amyloid β-protein fibril assembly with a distinct anti-parallel structure
    Feng Xu, Ziao Fu, Sharmila Dass, AnnMarie E. Kotarba, Judianne Davis, Steven O. Smith, William E. Van Nostrand · 2016 · Nature Communications
  70. Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brain
    Youjin Lee, Morgan R. Miller, Marty A. Fernandez, Elizabeth L. Berg, Adriana M. Prada, Qing Ouyang, Michael Schmidt, Jill L. Silverman, Tracy L. Young‐Pearse, Eric M. Morrow · 2021 · Brain
  71. Optical tissue clearing associated with 3D imaging: application in preclinical and clinical studies
    Cinzia Brenna, Carolina Simioni, Gabriele Varano, Ilaria Conti, Eva Costanzi, Mattia Melloni, Luca Maria Neri · 2022 · Histochemistry and Cell Biology
  72. Tau proteinopathies and the prion concept
    2020 · Progress in Molecular Biology and Translational Science
  73. A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies
    Edward M. Rockenstein, Cassia Overk, Kiren K. Ubhi, Michael Mante, Christina Patrick, Anthony Adame, Alejandro Bisquert, Margarita Trejo, Brian J. Spencer, Eliezer Masliah · 2015 · PLoS ONE · Retracted
  74. Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review)
    RUIQI FENG, Lijuan Li, Haiyan Yu, Min Liu, Wei Zhao · 2016 · Molecular Medicine Reports
  75. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates
    Aiko Robert, Michael Schöll, Thomas Vogels · 2021 · International Journal of Molecular Sciences
  76. Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease
    Trae Carroll, Sanjib K Guha, Keith W. Nehrke, Gail V.W. Johnson · 2021 · Biology
  77. Graphene quantum dots obstruct the membrane axis of Alzheimer's amyloid beta
    Huayuan Tang, Yuhuan Li, Aleksandr Käkinen, Nicholas Andrikopoulos, Yunxiang Sun, Eunbi Kwak, Thomas Paul Davis, Feng Ding, Pu Chun Ke · 2021 · Physical Chemistry Chemical Physics
  78. Region-Specific Characteristics of Astrocytes and Microglia: A Possible Involvement in Aging and Diseases
    Jae Lee, Sung Wook Kim, Kyong‐Tai Kim · 2022 · Cells
  79. Beyond Amyloid
    Rachel F. Lane, Diana W. Shineman, John Steele, Linda H Lee, Howard M. Fillit · 2012 · Advances in pharmacology
  80. “Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
    Silvia Zampar, Sonja E. Di Gregorio, Gustavo Grimmer, Joel C. Watts, Martin Ingelsson · 2024 · Frontiers in Neuroscience
  81. Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
    Feng Han, JiaQie Lee, Xi Chen, Jacob Ziontz, Tyler J. Ward, Susan M. Landau, Suzanne L. Baker, Theresa M. Harrison, William J. Jagust, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
  82. From Prion Diseases to Prion-Like Propagation Mechanisms of Neurodegenerative Diseases
    Isabelle Acquatella-Tran Van Ba, Thibaut Imberdis, Véronique Perrier · 2013 · International Journal of Cell Biology
  83. Pharmacological Modulators of Tau Aggregation and Spreading
    Antonio Dominguez‐Meijide, Eftychia Vasili, Tiago F. Outeiro · 2020 · Brain Sciences
  84. Loss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a Drosophila model expressing human tau
    Ting-Han Wu, Yuning Lu, Chia-Lung Chuang, Chia‐Lin Wu, Ann‐Shyn Chiang, David E. Krantz, Hui-Yun Chang · 2013 · Acta Neuropathologica
  85. Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies
    Jesús Ávila, Noemí Pallas‐Bazarra, Marta Bolós, Carmen Laura Sayas, Félix Hernández · 2015 · Expert Opinion on Therapeutic Targets
  86. Network anatomy in logopenic variant of primary progressive aphasia
    Maria Luisa Mandelli, Diego L. Lorca‐Puls, Sladjana Lukic, Maxime Montembeault, Andrea Gajardo‐Vidal, Abigail E. Licata, Aaron Scheffler, Giovanni Battistella, Stephanie M. Grasso, Rian Bogley et al. · 2023 · Human Brain Mapping
  87. Prion-like Mechanisms in Alzheimer's Disease
    Ruihua Yin, Lan Tan, Teng Jiang, Jin‐Tai Yu · 2014 · Current Alzheimer Research
  88. Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of disease
    Christopher Mezias, Eve LoCastro, Chuying Naomi Xia, Ashish Raj · 2017 · Acta Neuropathologica Communications
  89. Loss of presenilin function enhances tau phosphorylation and aggregation in mice
    Carlos M. Soto-Faguás, Paula Sanchez-Molina, Carlos A. Saura · 2021 · Acta Neuropathologica Communications
  90. Gene Therapy Models of Alzheimer’s Disease and Other Dementias
    Benjamin Combs, Andrew Kneynsberg, Nicholas M. Kanaan · 2015 · Methods in molecular biology
  91. Entorhinal tau pathology disrupts hippocampal-prefrontal oscillatory coupling during associative learning
    Stephanie E. Tanninen, Bardia Nouriziabari, Mark D. Morrissey, Rami Bakir, Robert D. Dayton, Ronald L. Klein, Kaori Takehara‐Nishiuchi · 2017 · Neurobiology of Aging
  92. Adrenomedullin, a Novel Target for Neurodegenerative Diseases
    Hilda Ferrero, Ignacio M. Larráyoz, Francisco Javier Gil-Bea, Alfredo Martı́nez, María Javier Ramírez · 2018 · Molecular Neurobiology
  93. Temporal progression of tau pathology and neuroinflammation in a rhesus monkey model of Alzheimer's disease
    Danielle Beckman, Giovanne Baroni Diniz, Sean P. Ott, Brad A. Hobson, Abhijit J. Chaudhari, Scott Muller, Yaping Chu, Akihiro Takano, Adam James Schwarz, Chien‐Lin Yeh et al. · 2024 · Alzheimer s & Dementia
  94. In Alzheimer's Disease, Hypometabolism in Low-Amyloid Brain Regions May Be a Functional Consequence of Pathologies in Connected Brain Regions
    Elisabeth Klupp, Stefan Förster, Timo Grimmer, Masoud Tahmasian, Igor Y. Yakushev, Christian Sorg, Behrooz H. Yousefi, Alexander E. Drzezga · 2014 · Brain Connectivity
  95. Tau immunization: a cautionary tale?
    Alexandra J. Mably, Daniel Kanmert, Jessica M. Mc Donald, Wen Liu, Barbara J. Caldarone, Cynthia Ann Lemere, Brian O’Nuallain, Kenneth S. Kosik, Dominic M. Walsh · 2014 · Neurobiology of Aging
  96. Insights into Mechanisms of Chronic Neurodegeneration
    Abigail B. Diack, James D. Alibhai, Rona M. Barron, Barry Matthew Bradford, Pedro Piccardo, Jean C. Manson · 2016 · International Journal of Molecular Sciences
  97. Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives
    Bruno Pietro Imbimbo, Madia Lozupone, Mark Watling, Francesco Panza · 2020 · Expert Opinion on Investigational Drugs
  98. An Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse Models
    Fokion Spanos, Shane Antony Liddelow · 2020 · Cells
  99. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid
    Tiziana Petrozziello, Ana Claudia Silva Amaral, Simon Dujardin, Sali M.K. Farhan, James Gin Man Chan, Bianca A. Trombetta, Pia Kivisäkk, Alexandra N. Mills, Evan A. Bordt, Spencer E. Kim et al. · 2021 · Brain Pathology
  100. Disrupting Neurons and Glial Cells Oneness in the Brain—The Possible Causal Role of Herpes Simplex Virus Type 1 (HSV-1) in Alzheimer’s Disease
    Matylda Barbara Mielcarska, Katarzyna Skowrońska, Zbigniew Wyżewski, Felix Ngosa Toka · 2021 · International Journal of Molecular Sciences